Skip to main content

Table 1 Baseline characteristics of participants in the intervention and control group

From: The effects of WeChat-based educational intervention in patients with ankylosing spondylitis: a randomized controlled trial

Variable

All (N = 118) N (%)

Intervention group (N = 59)

N (%)

Control group (N = 59)

N (%)

t/χ2/Z

P

Age (yr, mean ± SD)

29.93 ± 8.23

30.80 ± 8.82

29.07 ± 7.58

1.142

0.256a

Gender

   

0.457

0.499b

 Male

93 (78.8)

45 (76.3)

48 (81.4)

  

 Female

25 (21.2)

14 (23.7)

11 (18.6)

  

Educational level

   

0.218

0.897b

 Junior high school or below

30 (25.4)

15 (25.4)

15 (25.4)

  

 Senior high school

26 (22.0)

12 (20.3)

14 (23.7)

  

 College or above

62 (52.5)

32 (54.2)

30 (50.8)

  

Marital status

   

0

1.000b

 Single/divorced

62 (52.5)

31 (52.5)

31 (52.5)

  

 Married

56 (47.5)

28 (47.5)

28 (47.5)

  

Monthly per capita income (Â¥, yuan)

   

1.720

0.633b

 < 2200

34 (28.8)

16 (27.1)

18 (30.5)

  

 2200~3299

33 (28.0)

15 (25.4)

18 (30.5)

  

 3300~5499

23 (19.5)

11 (18.6)

12 (20.3)

  

 ≥ 5500

28 (23.7)

17 (28.8)

11 (18.6)

  

Medical insurance

   

0.160

0.689b

 Self-pay

82 (69.5)

40 (67.8)

42 (71.2)

  

 Medical insurance

36 (30.5)

19 (32.2)

17 (28.8)

  

Smoking status

   

1.502

0.472b

 Current smoking

36 (30.5)

19 (32.2)

17 (28.8)

  

 Never smoking

70 (59.3)

36 (61.0)

34 (57.6)

  

 Quit smoking

12 (10.2)

4 (6.8)

8 (13.6)

  

Medication

   

2.185

0.139b

 DMARDs

64 (54.2)

28 (47.5)

36 (61.0)

  

 DMARDs+biologics

54 (45.8)

31 (52.5)

23 (39.0)

  

Symptom duration (yr), M [IQR]

5.00 [6.00]

6.00 [7.00]

5.00 [7.00]

− 0.346

0.730c

Duration since diagnosis (yr), M [IQR]

3.00 [6.00]

3.00 [6.00]

3.00 [6.00]

− 0.577

0.564c

SF-36 subgroups

 Physical functioning

77.88 ± 18.67

77.54 ± 20.46

78.22 ± 16.86

− 0.196

0.845a

 Role physical, M [IQR]

50.00 [100.00]

50.00 [100.00]

50.00 [100.00]

− 0.490

0.624c

 Bodily pain

51.49 ± 20.31

53.97 ± 22.39

49.02 ± 17.84

1.328

0.187a

 General health

49.08 ± 21.29

49.81 ± 21.93

48.34 ± 20.79

0.375

0.708a

 Vitality

65.89 ± 18.95

67.63 ± 19.06

64.15 ± 18.85

0.996

0.321a

 Social functioning

70.46 ± 22.68

69.33 ± 23.45

71.59 ± 22.03

− 0.539

0.591a

 Role emotional

64.41 ± 43.52

66.67 ± 43.33

62.15 ± 43.97

0.562

0.575a

 Mental health

67.29 ± 15.39

67.12 ± 15.97

67.46 ± 14.92

− 0.119

0.905a

BDI-II, M [IQR]

5.00 [11.25]

5.00 [10.00]

6.00 [12.00]

− 0.543

0.587c

BAS-G

3.36 ± 2.31

3.31 ± 2.37

3.41 ± 2.27

− 0.234

0.815a

BASFI, M [IQR]

0.60 [1.70]

0.60 [1.90]

0.60 [1.50]

− 0.586

0.558c

Overall pain

3.24 ± 2.35

2.97 ± 2.33

3.51 ± 2.36

− 1.267

0.208a

Back pain

2.96 ± 2.33

2.76 ± 2.30

3.16 ± 2.36

− 0.929

0.355a

Nocturnal pain

3.02 ± 2.48

3.00 ± 2.33

3.05 ± 2.64

− 0.103

0.918a

Morning stiffness

2.45 ± 2.11

2.35 ± 1.93

2.56 ± 2.29

− 0.545

0.587a

  1. SD standard deviation, yr year, DMARDs disease-modifying anti-rheumatic drugs, M median, IQR interquartile range, BDI-II Beck Depression Inventory-II, BAS-G Bath Ankylosing Spondylitis Patient Global Score, BASFI Bath Ankylosing Spondylitis Functional Index
  2. aIndependent samples t test
  3. bChi-square test
  4. cMann-Whitney U test